1-8 of 8
Manan Shah
Close
Sort by
Journal Articles

Ibrutinib Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma: A Retrospective Single Center Experience from India

Rayaz Ahmed, MDDM, Dinesh Bhurani, MD DM, FRCPA, Narendra Agarwal, MD DM, Jyotsna Kapoor, MSc, Neha Gurha, MD, Manan Shah, MBBS, MHA, Prashant Narang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5561.
https://doi.org/10.1182/blood-2018-99-112348
Published: 2018
Journal Articles

Economic Impact of Disease Progression in Medicare Patients with Relapsed Multiple Myeloma

Joanna P. MacEwan, PhD, Katharine Batt, MD MSc, Wes Yin, PhD, Desi Peneva, MS, Steve Sison, MS, Seanna Vine, MS, Manan Shah, PhD, Clara Chen, PhD MS
Journal: Blood
Blood (2015) 126 (23): 2116.
https://doi.org/10.1182/blood.V126.23.2116.2116
Published: 2015
Journal Articles

Assessing the Economic Burden in Medicare Patients with Multiple Myeloma

Joanna P. MacEwan, PhD, Katharine Batt, MD MSc, Wes Yin, PhD, Desi Peneva, MS, Steve Sison, MS, Seanna Vine, MS, Manan Shah, PhD, Clara Chen, PhD MS
Journal: Blood
Blood (2015) 126 (23): 2100.
https://doi.org/10.1182/blood.V126.23.2100.2100
Published: 2015
Journal Articles

Treatment Sequencing Patterns Associated with Elderly Patients with Relapsed/Refractory Multiple Myeloma (MM) in the US Community Setting

Amanda M Farr, MPH, Marni Stott-Miller, Helen Varker, Danae Spencer, Manan Shah, PhD, Clara Chen, PhD MS
Journal: Blood
Blood (2015) 126 (23): 5392.
https://doi.org/10.1182/blood.V126.23.5392.5392
Published: 2015
Journal Articles

Front-Line (FL) Treatment Patterns Associated with Elderly Newly Diagnosed Multiple Myeloma (MM) Patients Treated in the US Community Setting

Amanda M Farr, MPH, Marni Stott-Miller, Helen Varker, Danae Spencer, Manan Shah, PhD, Clara Chen, PhD MS
Journal: Blood
Blood (2015) 126 (23): 5360.
https://doi.org/10.1182/blood.V126.23.5360.5360
Published: 2015
Journal Articles

ClaPD (Clarithromycin, Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma

Tomer M Mark, MD, MSc, Angelique Boyer, Adriana C Rossi, MD, Manan Shah, Roger N Pearse, MD, PhD, Faiza Zafar, PA, Karen Pekle, NP, Linda Tegnestam, RN, Erlinda A Sacris, RN, June Greenberg, RN, Stephanie Speaker, David Jayabalan, B.S.M.S, Scott A Ely, MD, MPH, Morton Coleman, MD, Selina Chen-Kiang, PhD, Ruben Niesvizky, MD
Journal: Blood
Blood (2012) 120 (21): 77.
https://doi.org/10.1182/blood.V120.21.77.77
Published: 2012
Journal Articles

ClaPD (Clarithromycin/[Biaxin®], Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma

Tomer M Mark, MD, MSc, Melissa Rodriguez, Manan Shah, Ryann Quinn, Jessica Campbell, Ramsey Abdullah, Roger N Pearse, MD, PhD, Faiza Zafar, PA, Karen Pekle, NP, Patrice Mignott, RN, David Jayabalan, B.S.M.S, Scott A Ely, MD, MPH, Morton Coleman, MD, Selina Chen-Kiang, PhD, Ruben Niesvizky, MD
Journal: Blood
Blood (2011) 118 (21): 635.
https://doi.org/10.1182/blood.V118.21.635.635
Published: 2011
Journal Articles

T-Bird (thalidomide, clarithromycin/[Biaxin®], lenalidomide/[Revlimid ® ], Dexamethasone) Therapy in Newly Diagnosed Symptomatic Multiple Myeloma

Tomer M Mark, MD, MSc, Manan Shah, Melissa Rodriguez, Ryann Quinn, Roger N Pearse, MD, PhD, Faiza Zafar, PA, Karen Pekle, NP, Patrice Mignott, RN, David Jayabalan, B.S.M.S, Scott A Ely, MD, MPH, Morton Coleman, MD, Selina Chen-Kiang, PhD, Ruben Niesvizky, MD
Journal: Blood
Blood (2011) 118 (21): 2937.
https://doi.org/10.1182/blood.V118.21.2937.2937
Published: 2011